| Log in
Photo Credit: Thinkstock

Company watch: Regulatory risks may weigh on Bain Capital-backed Emcure Pharma

10 July, 2017

India’s generics pharmaceutical industry has been hit over the past few years ever since the US Food and Drug Administration tightened its inspections of factories in the country ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Bain-backed drugmaker Emcure gets US FDA warning

Bain-backed drugmaker Emcure gets US FDA warning

Joseph Rai 2 years ago
The US Food and Drug Administration has sent a warning letter to Emcure...
Sanofi partners Bain Capital-backed Emcure for oncology drugs portfolio in India

Sanofi partners Bain Capital-backed Emcure for oncology drugs portfolio in India

Jasleen Kaur Batra 3 years ago
Global pharmaceutical major Sanofi has entered into a marketing and distribution...
Bain Capital-backed Emcure to buy half a dozen products from Sun Pharma-Ranbaxy

Bain Capital-backed Emcure to buy half a dozen products from Sun Pharma-Ranbaxy

Anuradha Verma 3 years ago
The Competition Commission of India (CCI) has approved the acquisition of around...
No Comments

Company watch: Regulatory risks may weigh on Bain Capital-backed Emcure Pharma

Powered by WordPress.com VIP